LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
Post-LOElevonorgestrel/ethinyl estradiol and ethinyl estradiol
ANDAORALTABLET
Approved
Dec 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL (levonorgestrel/ethinyl estradiol and ethinyl estradiol) by Teva is ovulation. First approved in 2017.
Drug data last refreshed 19h ago
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Teva
Israel - Petach Tikva
Worked on LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.